Fermenta Biotech has informed that the Board of Directors of the Company at its meeting held on November 11, 2022 has approved the unaudited financial results for the quarter and half year ended September 30, 2022 (Standalone and Consolidated) as enclosed. It has enclosed the Limited Review Report dated November 11, 2022 (along with the aforesaid Consolidated and Standalone unaudited financial Results) issued by the Company's Statutory Auditors, SRBC & Co. LLP. The Board meeting commenced at 11.45 am and concluded at 02.55 pm.
The above information is a part of company’s filings submitted to BSE.
